Kyung U. Hong, Ph.D.
Education:
B.S. (High Honors), Department of Environmental Toxicology, University of California @ Davis, Davis, CA; 1996
M.S., Toxicology Program, Department of Environmental Medicine, University of Rochester, School of Medicine & Dentistry, Rochester, NY; 2001
Ph.D., Toxicology Program, Department of Environmental Medicine, University of Rochester, School of Medicine & Dentistry, Rochester, NY; 2003
Postdoctoral Fellowship, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea; 2003-2007
Curriculum Vitae
Current Positions:
Assistant Professor, Department of Pharmacology & Toxicology, University of Louisville School of Medicine, Louisville, KY
Member, Experimental Therapeutics & Diagnostics Program, Brown Cancer Center
Contact Information:
Department of Pharmacology & Toxicology
University of Louisville
Clinical & Translational Research Building, Rm 118
505 South Hancock Street
Louisville, KY 40202
Phone: (502) 821-4077
Email: kyung.hong@louisville.edu
Research Description:
Since 2018, Dr. Hong has been working closely with Dr. David W. Hein, who is a leading expert in arylamine N-acetyltransferase (NAT) biology. His current research efforts are focused on: 1) contribution of NAT1 to breast cancer growth and metastasis; 2) the role of human NAT2 in cellular metabolism and insulin sensitivity in hepatocytes; 3) the novel link between dietary exposure to heterocyclic amines (HCAs) and development of insulin resistance; and, most recently, 4) the bladder cancer risk allele of NAT2, rs1495741.
Literature Cited:
- Hong KU, Gardner JQ, Doll MA, Stepp MW, Wilkey DW, Benz FW, Cai J, Merchant ML, Hein DW. Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells. Data in Brief 2022 Sep 24;45:108634. doi: 10.1016/j.dib.2022.108634. eCollection 2022 Dec. PMID: 36426076. PMCID: PMC9679541
- Hong KU, Tagnedji AH, Doll MA, Walls KM, Hein DW. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells. Journal of Cancer Research & Clinical Oncology 2022 Nov 3. doi: 10.1007/s00432-022-04436-w . Online ahead of print. PMID: 36329350.
- Hong KU, Gardner JQ, Doll MA, Stepp MW, Wilkey DW, Benz FW, Cai J, Merchant ML, Hein DW. Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis. Toxicology Reports 2022 Jul 19;9:1566-1573. doi: 10.1016/j.toxrep.2022.07.010. eCollection 2022. PMID: 36158865. PMCID: PMC9500399
- Hong KU, Salazar-González RA, Walls KM, Hein DW. Transcriptional regulation of human arylamine N-acetyltransferase 2 gene by glucose and insulin in liver cancer cell lines. Toxicolotical Sciences 2022 Nov 23;190(2):158-172. doi: 10.1093/toxsci/kfac103. PMID: 36156098. PMCID: PMC9702998 (available on 2023-09-26).
- Doll MA, Ray AR, Salazar-González RA, Shah PP, Vega AA, Sears SM, Krueger AM, Hong KU, Beverly LJ, Hein DW. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis. Molecular Carcinogenesis 2022 May;61(5):481-493. doi: 10.1002/mc.23392. Epub 2022 Feb 8. PMID: 35133049. PMCID: PMC9018511 (available on 2023-05-01).
- Hong KU, Doll MA, Lykoudi A, Salazar-González RA, Habil MR, Walls KM, Bakr AF, Ghare SS, Barve SS, Arteel GE, Hein DW. Acetylator genotype-dependent dyslipidemia in rats congenic for N-acetyltransferase2. Toxicology Reports 2020 Sep 28;7:1319-1330. doi: 10.1016/j.toxrep.2020.09.011. PMID: 33083237. PMCID: PMC7553889.
- Carlisle SM, Trainor PJ, Hong KU, Doll MA, Hein DW. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism. Scientific Reports 2020 Jun 17;10(1):9804. doi: 10.1038/s41598-020-66863-4. PMID: 32555504. PMCID: PMC7299936.
- Stepp MW, Salazar-González RA, Hong KU, Doll MA, Hein DW. N-Acetyltransferase 1 knockout elevates acetyl coenzyme A levels and reduces anchorage-independent growth in human breast cancer cell lines. Journal of Oncology 2019 Aug 20;2019:3860426. doi: 10.1155/2019/3860426. PMID: 31531019. PMCID: PMC6720663
- Al-Maqtari T, Hong KU, Vajravelu BN, Moktar A, Cao P, Moore JB 4th, Bolli R. Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells. PLoS One 2017 Mar 29;12(3):e0174242. doi: 10.1371/journal.pone.0174242. PMID: 28355297. PMCID: PMC5371315
- Vajravelu BN, Hong KU, Al-Maqtari T, Cao P, Keith MC, Wysoczynski M, Zhao J, Moore JB 4th, Bolli R. C-Kit promotes growth and migration of human cardiac progenitor cells via the PI3K-AKT and MEK-ERK pathways. PLoS One 2015 Oct 6;10(10):e0140798. doi: 10.1371/journal.pone.0140798. eCollection 2015. PMID: 26474484. PMCID: PMC4608800
Complete List of Published Work in MyBibliography:
https://www.ncbi.nlm.nih.gov/myncbi/1dGr9mB_Lu75k/bibliography/public/